Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Toh Kean Meng Melvin — Virios Therapeutics, Inc. insider · InsiderLens

Home / Insiders / Toh Kean Meng Melvin

Toh Kean Meng Melvin

Director at Virios Therapeutics, Inc. · on record since Oct 17, 2024

Insider trading activity of Toh Kean Meng Melvin

No transactions on record for Toh Kean Meng Melvin.

Track record of Toh Kean Meng Melvin

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Toh Kean Meng Melvin

Co-insiders of Toh Kean Meng Melvin

Burch Richard AlanVirios Therapeutics, Inc.
CK Life Sciences Intl (Holdings) IncVirios Therapeutics, Inc.
Conjoint Inc.Virios Therapeutics, Inc.
De La Rosa AbelVirios Therapeutics, Inc.
Duncan Gregory ScottVirios Therapeutics, Inc.
Gendreau Roger MichaelVirios Therapeutics, Inc.
Grosswald RalphVirios Therapeutics, Inc.
Keefer David RVirios Therapeutics, Inc.
Pridgen WilliamVirios Therapeutics, Inc.
Sealbond LtdVirios Therapeutics, Inc.
Thomas John CVirios Therapeutics, Inc.
Walsh AngelaVirios Therapeutics, Inc.
Whitley Richard JamesVirios Therapeutics, Inc.
Yu Ying Choi Alan AbelVirios Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters